Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sutro Biopharma, Inc. - Common Stock (NQ:STRO)

0.9700 +0.0600 (+6.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 478,098
Open 0.9200
Bid (Size) 0.9103 (11)
Ask (Size) 0.9506 (75)
Prev. Close 0.9100
Today's Range 0.9100 - 1.010
52wk Range 0.5231 - 4.800
Shares Outstanding 60,416,916
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga

Performance

YTD
-49.7%
-49.7%
1 Month
+23.8%
+23.8%
3 Month
+19.6%
+19.6%
6 Month
-22.4%
-22.4%
1 Year
-79.0%
-79.0%

More News

Read More
Sutro Biopharma Inc (NASDAQ:STRO) Reports Q2 2025 Revenue Beat and Narrower Losses, Shares Rise in After-Hours Trading
Via Chartmill
Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Expert Outlook: Sutro Biopharma Through The Eyes Of 6 Analysts
Via Benzinga
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
A Glimpse Into The Expert Outlook On Sutro Biopharma Through 5 Analysts
Via Benzinga
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
Which stocks are moving on Monday?
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 15
Via Talk Markets
Topics Stocks / Equities
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.
Via Chartmill
Which stocks are experiencing notable movement on Friday?
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline
Via Benzinga
Dow Jumps Over 600 Points; US Consumer Sentiment Tumbles In March
Via Benzinga
Topics Stocks
Nasdaq Surges 1.5%; Ulta Beauty Posts Upbeat Results
Via Benzinga
This T-Mobile Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Sutro Biopharma, Inc. - Common Stock publicly traded?
Yes, Sutro Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Sutro Biopharma, Inc. - Common Stock trade on?
Sutro Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sutro Biopharma, Inc. - Common Stock?
The ticker symbol for Sutro Biopharma, Inc. - Common Stock is STRO on the Nasdaq Stock Market
What is the current price of Sutro Biopharma, Inc. - Common Stock?
The current price of Sutro Biopharma, Inc. - Common Stock is 0.9700
When was Sutro Biopharma, Inc. - Common Stock last traded?
The last trade of Sutro Biopharma, Inc. - Common Stock was at 09/11/25 04:00 PM ET
What is the market capitalization of Sutro Biopharma, Inc. - Common Stock?
The market capitalization of Sutro Biopharma, Inc. - Common Stock is 58.60M
How many shares of Sutro Biopharma, Inc. - Common Stock are outstanding?
Sutro Biopharma, Inc. - Common Stock has 59M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.